Immunological Interaction Between the Host and Candida Albicans Biofilm

Candida albicans is one of the most common nosocomial infection and the onset relies on the host immune status. The purpose of this study is to determine the immunological profile of patients infected with Candida albicans, that could ideally lead to a strategy to identify patients who could benefit from prophylaxis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Candidiasis Bacterial Infections and Mycoses Infections Mycoses

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitair Ziekenhuis Leuven

Leuven, Flemish Brabant, 3000, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients infected with Candida albicans
Patients not infected with Candida albicans

Exclusion criteria

Underage patients
Non consenting patients
Unconscious patients

Treatment and study plan

Primary outcomes

Immunological phenotyping of patients

Time frame: 2 months

Secondary outcomes

Mannose Binding Lectin levels

Time frame: 1 month

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Official study title

Immunological and Molecular Interaction Between the Host and Candida Albicans Biofilm

Important dates

Study start: 2013
Primary completion: 2015
Study completion: 2016
First posted: Aug 9, 2013
Registry last updated: Dec 7, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed